Dingxiang Doctor: Exploration of Health Communication on the Commercial Content Platform

Author:

Wang Zixuan

Abstract

In the report of the 19th National Congress of the Communist Party of China (CPC), in the part of "improving the people's livelihood and strengthening and innovating social governance", it was clearly stated that "implementing the healthy China strategy". With the emergence of COVID-19 in 2020, the health problem has once again aroused heated discussion among the whole society. How to do a good job in health communication has become a difficult problem for the media. COVID-19 has brought more new health media platforms into the vision of Internet users, and this kind of health communication media has become an emerging channel for users to obtain health information and seek medical advice. This paper taking Dingxiang Doctor as a specific case, analyzes the communication factors and commercial factors that lead to the success of a commercialized new media platform for health knowledge. At the same time, combined with the example of Dingxiang Doctor being banned due to its content, it analyzes the development difficulties of health communication in the context of the COVID-19 epidemic, and puts forward suggestions for improvement according to the current situation.

Publisher

Boya Century Publishing

Reference10 articles.

1. 50th China Statistical Report on Internet Development, 2022

2. Tang Hong & Yang Chong. Influencing factors of communication effectiveness on –health-related articles communicated by one Wechat public account. Chinese Journal of Health Education, 2022,(04),364-366+383.

3. Fu Shaoqiang & Chen Miao. Analysis on the marketing mode of health new media platform - taking "Dingxiang Doctor" as an example. Media, 2021(05),62-64.

4. Jing Yuan. "Dingxiang Doctor" An Analysis of the Success of "Doctor Clove" official account. Media,2021(15),56-58.

5. World Health Organization.Managing epidemics: key facts about major deadly diseases.Geneva: World Health Organization, 2018.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3